1. Home
  2. ACNT vs HURA Comparison

ACNT vs HURA Comparison

Compare ACNT & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascent Industries Co.

ACNT

Ascent Industries Co.

HOLD

Current Price

$16.49

Market Cap

145.5M

Sector

Industrials

ML Signal

HOLD

Logo TuHURA Biosciences Inc.

HURA

TuHURA Biosciences Inc.

HOLD

Current Price

$0.76

Market Cap

131.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACNT
HURA
Founded
1945
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
145.5M
131.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACNT
HURA
Price
$16.49
$0.76
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
68.5K
620.5K
Earning Date
11-04-2025
02-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$171,413,000.00
N/A
Revenue This Year
$22.72
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$173.13
N/A
Revenue Growth
65.05
N/A
52 Week Low
$10.76
$0.70
52 Week High
$16.84
$5.50

Technical Indicators

Market Signals
Indicator
ACNT
HURA
Relative Strength Index (RSI) 70.39 26.25
Support Level $15.75 $0.70
Resistance Level $16.22 $0.85
Average True Range (ATR) 0.39 0.10
MACD -0.00 0.00
Stochastic Oscillator 79.73 11.79

Price Performance

Historical Comparison
ACNT
HURA

About ACNT Ascent Industries Co.

Ascent Industries Co is a specialty chemicals platform focused on the development, production, and distribution of tailored, performance-driven chemical solutions. It has one reportable segment: Specialty Chemicals. The Specialty Chemicals segment includes the operating results of the Company's plants involved in the production of specialty chemicals and produces critical ingredients and process aids for the oil & gas, household, industrial and institutional (HII), personal care, coatings, adhesives, sealants and elastomers (CASE), pulp and paper, textile, automotive, agricultural, water treatment, construction and other industries.

About HURA TuHURA Biosciences Inc.

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.

Share on Social Networks: